ALC:SWX
Alcon AG
CHFÂ 53.76
arrow_upward
+0.19%(+0.100) 1D
Sep 21, 9:40:30 AM GMT+2 · CHF
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALC...
Open
CHFÂ 53.62
High
CHFÂ 53.78
Low
CHFÂ 53.52
Mkt. cap
26.78B
Avg. vol.
1.12M
Volume
66.39K
Dividend
0.52%
Quarterly dividend
CHFÂ 0.07
Ex-dividend date
May 5, 2026
P/E ratio
50.18
52-wk high
CHFÂ 68.34
52-wk low
CHFÂ 47.80
EPS
CHFÂ 1.07
Shares outstanding
499.70M
No. of employees
25K
Open
CHFÂ 53.62
High
CHFÂ 53.78
Low
CHFÂ 53.52
Mkt. cap
26.78B
Avg. vol.
1.12M
Volume
66.39K
Dividend
0.52%
Quarterly dividend
CHFÂ 0.07
Ex-dividend date
May 5, 2026
P/E ratio
50.18
52-wk high
CHFÂ 68.34
52-wk low
CHFÂ 47.80
EPS
CHFÂ 1.07
Shares outstanding
499.70M
No. of employees
25K
News stories
From web sources and news partners
AD HOC NEWS
·
3 days ago
Alcon stock heads into the open after a 3.0 percent slide
CarePlus VietNam
·
2 months ago
Alcon (ALC) Q1 2026 Earnings: EPS Beat Amid Mixed Sentiment, Stock Edges Lower - Estimate Revision Count
Profile
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
About Alcon AG
CEODavid J. Endicott
Employees25K
Founded1945
HeadquartersGeneva, Geneva, Switzerland
SectorMedical device
Websitealcon.com